Alzheimer’s Trials Exclude Black Patients at ‘Astonishing’ Rate
Originally published April 21, 2022 by Bloomberg
A Bloomberg News analysis of CDC data finds that while Black people are almost twice as likely to develop Alzheimer’s than white people, they only account for 2 percent of patients included in related drug treatment trials.
Read the full story from Bloomberg here.
This entry was posted in News, Outside CDS.